The characterization of germline pathogenic variants in the BRCA1 and BRCA2 genes are relevant for prevention setting and for the clinical management of hereditary breast and ovarian cancer (HBOC) [6]. Here, BRCA1 is linked to Hereditary breast and ovarian cancer syndrome.